Skip to main content
. 2021 Feb 16;96(7):e1054–e1062. doi: 10.1212/WNL.0000000000011412

Table 4.

Genetic Rearrangement Characteristics of Tests With a Molecular Diagnosis of FSHD1, FSHD2, or All Non-FSHD1,2, n (%)

graphic file with name NEUROLOGY2020116186TT4.jpg